This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board to review September 2026 quarter and half-year results
JUBLCPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.2 pts more than Nifty Microcap 250 and 0.6 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board will meet on November 5, 2026 to approve unaudited standalone and consolidated results for the quarter and six months ended September 30, 2026. The notice provides no profit, revenue, cash flow, debt, or auditor details, so the results' direction cannot be assessed.
The upcoming results may drive near-term share price volatility, but no financial performance figures are disclosed yet.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹589.8 Cr | ₹513.0 Cr | +15.0% |
| Operating profit | ₹17.63 Cr | ₹58.31 Cr | −69.8% |
| Profit after tax | ₹17.58 Cr | ₹42.28 Cr | −58.4% |
| EBITDA margin | 4.4% | 12.5% | −8.0 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.